Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1532 entries
Sorted by: Best Match Show Resources per page
[The present and future status of clinical electroencephalography].

Iryo

Honma I.
PMID: 5686372
Iryo. 1968 Apr;22(4):486-91.

No abstract available.

Cite
Honma I. [The present and future status of clinical electroencephalography]. Iryo. 1968;22(4):486-91
Honma, I. (1968). [The present and future status of clinical electroencephalography]. Iryo, 22(4), 486-91.
Honma, I. "[The present and future status of clinical electroencephalography]." Iryo vol. 22,4 (1968): 486-91.
Honma I. [The present and future status of clinical electroencephalography]. Iryo. 1968 Apr;22(4):486-91. Japanese. PMID: 5686372.
Copy Download .nbib Format: NLM
Controlled synthesis of nanocrystalline Li2MnSiO4 particles for high capacity cathode application in lithium-ion batteries.

Chemical communications (Cambridge, England)

Kempaiah DM, Rangappa D, Honma I.
PMID: 22307175
Chem Commun (Camb). 2012 Mar 11;48(21):2698-700. doi: 10.1039/c2cc17234h. Epub 2012 Feb 03.

Monodispersed Li(2)MnSiO(4) nanoparticles are synthesized via a supercritical solvothermal method at 300 °C for 5 min reaction time. The as-synthesized nanoparticles are free from impurities and have 15-20 nm diameter. After coating with conductive polymer, a discharge capacity of...

Cite
Kempaiah DM, Rangappa D, Honma I. Controlled synthesis of nanocrystalline Li2MnSiO4 particles for high capacity cathode application in lithium-ion batteries. Chem Commun (Camb). 2012;48(21):2698-700doi: 10.1039/c2cc17234h.
Kempaiah, D. M., Rangappa, D., & Honma, I. (2012). Controlled synthesis of nanocrystalline Li2MnSiO4 particles for high capacity cathode application in lithium-ion batteries. Chemical communications (Cambridge, England), 48(21), 2698-700. https://doi.org/10.1039/c2cc17234h
Kempaiah, Devaraju M, et al. "Controlled synthesis of nanocrystalline Li2MnSiO4 particles for high capacity cathode application in lithium-ion batteries." Chemical communications (Cambridge, England) vol. 48,21 (2012): 2698-700. doi: https://doi.org/10.1039/c2cc17234h
Kempaiah DM, Rangappa D, Honma I. Controlled synthesis of nanocrystalline Li2MnSiO4 particles for high capacity cathode application in lithium-ion batteries. Chem Commun (Camb). 2012 Mar 11;48(21):2698-700. doi: 10.1039/c2cc17234h. Epub 2012 Feb 03. PMID: 22307175.
Copy Download .nbib Format: NLM
STIM and Orai isoform expression in pregnant human myometrium: a potential role in calcium signaling during pregnancy.

Frontiers in physiology

Chin-Smith EC, Slater DM, Johnson MR, Tribe RM.
PMID: 24834055
Front Physiol. 2014 May 06;5:169. doi: 10.3389/fphys.2014.00169. eCollection 2014.

Store-operated calcium (Ca(2+)) entry (SOCE) can be mediated by two novel proteins, STIM/Orai. We have previously demonstrated that members of the TRPC family, putative basal and store operated calcium entry channels, are present in human myometrium and regulated by...

Cite
Chin-Smith EC, Slater DM, Johnson MR, et al. STIM and Orai isoform expression in pregnant human myometrium: a potential role in calcium signaling during pregnancy. Front Physiol. 2014;5:169doi: 10.3389/fphys.2014.00169.
Chin-Smith, E. C., Slater, D. M., Johnson, M. R., & Tribe, R. M. (2014). STIM and Orai isoform expression in pregnant human myometrium: a potential role in calcium signaling during pregnancy. Frontiers in physiology, 5169. https://doi.org/10.3389/fphys.2014.00169
Chin-Smith, Evonne C, et al. "STIM and Orai isoform expression in pregnant human myometrium: a potential role in calcium signaling during pregnancy." Frontiers in physiology vol. 5 (2014): 169. doi: https://doi.org/10.3389/fphys.2014.00169
Chin-Smith EC, Slater DM, Johnson MR, Tribe RM. STIM and Orai isoform expression in pregnant human myometrium: a potential role in calcium signaling during pregnancy. Front Physiol. 2014 May 06;5:169. doi: 10.3389/fphys.2014.00169. eCollection 2014. PMID: 24834055; PMCID: PMC4018559.
Copy Download .nbib Format: NLM
Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis.

Oncotarget

Omae K, Tsujimoto Y, Honda M, Kondo T, Tanabe K, Fukuhara S, Furukawa TA.
PMID: 28978165
Oncotarget. 2017 Aug 18;8(40):68890-68898. doi: 10.18632/oncotarget.20323. eCollection 2017 Sep 15.

OBJECTIVE: To determine the comparative efficacy and safety of all available bone-modifying agents (BMAs) for the treatment of bone metastases in patients with advanced renal cell carcinoma (RCC).RESULTS: Three studies (259 patients) were identified for the systematic review. Two...

Cite
Omae K, Tsujimoto Y, Honda M, et al. Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8(40):68890-68898doi: 10.18632/oncotarget.20323.
Omae, K., Tsujimoto, Y., Honda, M., Kondo, T., Tanabe, K., Fukuhara, S., & Furukawa, T. A. (2017). Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis. Oncotarget, 8(40), 68890-68898. https://doi.org/10.18632/oncotarget.20323
Omae, Kenji, et al. "Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis." Oncotarget vol. 8,40 (2017): 68890-68898. doi: https://doi.org/10.18632/oncotarget.20323
Omae K, Tsujimoto Y, Honda M, Kondo T, Tanabe K, Fukuhara S, Furukawa TA. Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis. Oncotarget. 2017 Aug 18;8(40):68890-68898. doi: 10.18632/oncotarget.20323. eCollection 2017 Sep 15. PMID: 28978165; PMCID: PMC5620305.
Copy Download .nbib Format: NLM
Medicinal Chemistry: Where Are All the Women?.

ACS medicinal chemistry letters

Huryn DM, Bolognesi ML, Young WB.
PMID: 28947931
ACS Med Chem Lett. 2017 Aug 25;8(9):900-902. doi: 10.1021/acsmedchemlett.7b00321. eCollection 2017 Sep 14.

A review of multiple parameters including membership in professional organizations, corresponding authorship of medicinal chemistry journal articles, and representation in professional and leadership positions reveals that the percentage of women who participate in professional medicinal chemistry activities is less...

Cite
Huryn DM, Bolognesi ML, Young WB. Medicinal Chemistry: Where Are All the Women?. ACS Med Chem Lett. 2017;8(9):900-902doi: 10.1021/acsmedchemlett.7b00321.
Huryn, D. M., Bolognesi, M. L., & Young, W. B. (2017). Medicinal Chemistry: Where Are All the Women?. ACS medicinal chemistry letters, 8(9), 900-902. https://doi.org/10.1021/acsmedchemlett.7b00321
Huryn, Donna M, et al. "Medicinal Chemistry: Where Are All the Women?." ACS medicinal chemistry letters vol. 8,9 (2017): 900-902. doi: https://doi.org/10.1021/acsmedchemlett.7b00321
Huryn DM, Bolognesi ML, Young WB. Medicinal Chemistry: Where Are All the Women?. ACS Med Chem Lett. 2017 Aug 25;8(9):900-902. doi: 10.1021/acsmedchemlett.7b00321. eCollection 2017 Sep 14. PMID: 28947931; PMCID: PMC5601382.
Copy Download .nbib Format: NLM
Large-Scale Shell-Model Analysis of the Neutrinoless ββ Decay of ^{48}Ca.

Physical review letters

Iwata Y, Shimizu N, Otsuka T, Utsuno Y, Menéndez J, Honma M, Abe T.
PMID: 27035297
Phys Rev Lett. 2016 Mar 18;116(11):112502. doi: 10.1103/PhysRevLett.116.112502. Epub 2016 Mar 15.

We present the nuclear matrix element for the neutrinoless double-beta decay of ^{48}Ca based on large-scale shell-model calculations including two harmonic oscillator shells (sd and pf shells). The excitation spectra of ^{48}Ca and ^{48}Ti, and the two-neutrino double-beta decay...

Cite
Iwata Y, Shimizu N, Otsuka T, et al. Large-Scale Shell-Model Analysis of the Neutrinoless ββ Decay of ^{48}Ca. Phys Rev Lett. 2016;116(11):112502doi: 10.1103/PhysRevLett.116.112502.
Iwata, Y., Shimizu, N., Otsuka, T., Utsuno, Y., Menéndez, J., Honma, M., & Abe, T. (2016). Large-Scale Shell-Model Analysis of the Neutrinoless ββ Decay of ^{48}Ca. Physical review letters, 116(11), 112502. https://doi.org/10.1103/PhysRevLett.116.112502
Iwata, Y, et al. "Large-Scale Shell-Model Analysis of the Neutrinoless ββ Decay of ^{48}Ca." Physical review letters vol. 116,11 (2016): 112502. doi: https://doi.org/10.1103/PhysRevLett.116.112502
Iwata Y, Shimizu N, Otsuka T, Utsuno Y, Menéndez J, Honma M, Abe T. Large-Scale Shell-Model Analysis of the Neutrinoless ββ Decay of ^{48}Ca. Phys Rev Lett. 2016 Mar 18;116(11):112502. doi: 10.1103/PhysRevLett.116.112502. Epub 2016 Mar 15. PMID: 27035297.
Copy Download .nbib Format: NLM
Simulation in training questionnaire design.

Nurse researcher

Mick C, Donna M.
PMID: 27702020
Nurse Res. 1994 Jan 01;1(2):52-61. doi: 10.7748/nr.1.2.52.s7.

Teaching students about the practicalities of questionnaire design and application can raise serious ethical problems if patients are involved in their research. The authors describe how the skills can be effectively taught without recourse to involving patients at all.

Cite
Mick C, Donna M. Simulation in training questionnaire design. Nurse Res. 1994;1(2):52-61doi: 10.7748/nr.1.2.52.s7.
Mick, C., & Donna, M. (1994). Simulation in training questionnaire design. Nurse researcher, 1(2), 52-61. https://doi.org/10.7748/nr.1.2.52.s7
Mick, Coleman, and Donna, Mead. "Simulation in training questionnaire design." Nurse researcher vol. 1,2 (1994): 52-61. doi: https://doi.org/10.7748/nr.1.2.52.s7
Mick C, Donna M. Simulation in training questionnaire design. Nurse Res. 1994 Jan 01;1(2):52-61. doi: 10.7748/nr.1.2.52.s7. PMID: 27702020.
Copy Download .nbib Format: NLM
A catalog of hemizygous variation in 127 22q11 deletion patients.

Human genome variation

Hestand MS, Nowakowska BA, Vergaelen E, Van Houdt J, Dehaspe L, Suhl JA, Del-Favero J, Mortier G, Zackai E, Swillen A, Devriendt K, Gur RE, McDonald-McGinn DM, Warren ST, Emanuel BS, Vermeesch JR.
PMID: 27274857
Hum Genome Var. 2016 Jan 14;3:15065. doi: 10.1038/hgv.2015.65. eCollection 2016.

The 22q11.2 deletion syndrome is the most common microdeletion disorder, with wide phenotypic variability. To investigate variation within the non-deleted allele we performed targeted resequencing of the 22q11.2 region for 127 patients, identifying multiple deletion sizes, including two deletions...

Cite
Hestand MS, Nowakowska BA, Vergaelen E, et al. A catalog of hemizygous variation in 127 22q11 deletion patients. Hum Genome Var. 2016;3:15065doi: 10.1038/hgv.2015.65.
Hestand, M. S., Nowakowska, B. A., Vergaelen, E., Van Houdt, J., Dehaspe, L., Suhl, J. A., Del-Favero, J., Mortier, G., Zackai, E., Swillen, A., Devriendt, K., Gur, R. E., McDonald-McGinn, D. M., Warren, S. T., Emanuel, B. S., & Vermeesch, J. R. (2016). A catalog of hemizygous variation in 127 22q11 deletion patients. Human genome variation, 315065. https://doi.org/10.1038/hgv.2015.65
Hestand, Matthew S, et al. "A catalog of hemizygous variation in 127 22q11 deletion patients." Human genome variation vol. 3 (2016): 15065. doi: https://doi.org/10.1038/hgv.2015.65
Hestand MS, Nowakowska BA, Vergaelen E, Van Houdt J, Dehaspe L, Suhl JA, Del-Favero J, Mortier G, Zackai E, Swillen A, Devriendt K, Gur RE, McDonald-McGinn DM, Warren ST, Emanuel BS, Vermeesch JR. A catalog of hemizygous variation in 127 22q11 deletion patients. Hum Genome Var. 2016 Jan 14;3:15065. doi: 10.1038/hgv.2015.65. eCollection 2016. PMID: 27274857; PMCID: PMC4892188.
Copy Download .nbib Format: NLM
Biogenesis of Protein Bodies in Embryonic Axes of Soybean Seeds (Glycine max. cv. Enrei).

Bioscience, biotechnology, and biochemistry

Monma M, Sugimoto T, Hashizume K, Saio K.
PMID: 27286373
Biosci Biotechnol Biochem. 1992 Jan;56(7):1036-40. doi: 10.1271/bbb.56.1036.

Protein bodies in embryonic axes of soybean seeds have inclusion structures containing phytin globoids. Biogenesis of the protein bodies during seed development was examined by transmission electron microscopy. Protein bodies in embryonic axes originated from central vacuoles. The central...

Cite
Monma M, Sugimoto T, Hashizume K, et al. Biogenesis of Protein Bodies in Embryonic Axes of Soybean Seeds (Glycine max. cv. Enrei). Biosci Biotechnol Biochem. 1992;56(7):1036-40doi: 10.1271/bbb.56.1036.
Monma, M., Sugimoto, T., Hashizume, K., & Saio, K. (1992). Biogenesis of Protein Bodies in Embryonic Axes of Soybean Seeds (Glycine max. cv. Enrei). Bioscience, biotechnology, and biochemistry, 56(7), 1036-40. https://doi.org/10.1271/bbb.56.1036
Monma, M, et al. "Biogenesis of Protein Bodies in Embryonic Axes of Soybean Seeds (Glycine max. cv. Enrei)." Bioscience, biotechnology, and biochemistry vol. 56,7 (1992): 1036-40. doi: https://doi.org/10.1271/bbb.56.1036
Monma M, Sugimoto T, Hashizume K, Saio K. Biogenesis of Protein Bodies in Embryonic Axes of Soybean Seeds (Glycine max. cv. Enrei). Biosci Biotechnol Biochem. 1992 Jan;56(7):1036-40. doi: 10.1271/bbb.56.1036. PMID: 27286373.
Copy Download .nbib Format: NLM
Assumptions at the philosophical and programmatic levels in evaluation.

Evaluation and program planning

Mertens DM.
PMID: 27340047
Eval Program Plann. 2016 Dec;59:102-108. doi: 10.1016/j.evalprogplan.2016.05.010. Epub 2016 Jun 03.

Stakeholders and evaluators hold a variety of levels of assumptions at the philosophical, methodological, and programmatic levels. The use of a transformative philosophical framework is presented as a way for evaluators to become more aware of the implications of...

Cite
Mertens DM. Assumptions at the philosophical and programmatic levels in evaluation. Eval Program Plann. 2016;59:102-108doi: 10.1016/j.evalprogplan.2016.05.010.
Mertens, D. M. (2016). Assumptions at the philosophical and programmatic levels in evaluation. Evaluation and program planning, 59102-108. https://doi.org/10.1016/j.evalprogplan.2016.05.010
Mertens, Donna M. "Assumptions at the philosophical and programmatic levels in evaluation." Evaluation and program planning vol. 59 (2016): 102-108. doi: https://doi.org/10.1016/j.evalprogplan.2016.05.010
Mertens DM. Assumptions at the philosophical and programmatic levels in evaluation. Eval Program Plann. 2016 Dec;59:102-108. doi: 10.1016/j.evalprogplan.2016.05.010. Epub 2016 Jun 03. PMID: 27340047.
Copy Download .nbib Format: NLM
A patient with epileptic psychosis who had rare acute episodic symptoms.

Epilepsy & behavior case reports

Horinouchi T, Oyanagi Y, Umemoto Y, Hosokawa Y, Honma H, Matsubara S.
PMID: 25667891
Epilepsy Behav Case Rep. 2014 Aug 19;2:133-5. doi: 10.1016/j.ebcr.2014.07.004. eCollection 2014.

This is a case report of a 38-year-old woman with temporal lobe epilepsy and epileptic psychoses. The psychoses consisted of three rare symptoms that were "a distortion in the sense of time," "what should be there disappears," and "the...

Cite
Horinouchi T, Oyanagi Y, Umemoto Y, et al. A patient with epileptic psychosis who had rare acute episodic symptoms. Epilepsy Behav Case Rep. 2014;2:133-5doi: 10.1016/j.ebcr.2014.07.004.
Horinouchi, T., Oyanagi, Y., Umemoto, Y., Hosokawa, Y., Honma, H., & Matsubara, S. (2014). A patient with epileptic psychosis who had rare acute episodic symptoms. Epilepsy & behavior case reports, 2133-5. https://doi.org/10.1016/j.ebcr.2014.07.004
Horinouchi, Toru, et al. "A patient with epileptic psychosis who had rare acute episodic symptoms." Epilepsy & behavior case reports vol. 2 (2014): 133-5. doi: https://doi.org/10.1016/j.ebcr.2014.07.004
Horinouchi T, Oyanagi Y, Umemoto Y, Hosokawa Y, Honma H, Matsubara S. A patient with epileptic psychosis who had rare acute episodic symptoms. Epilepsy Behav Case Rep. 2014 Aug 19;2:133-5. doi: 10.1016/j.ebcr.2014.07.004. eCollection 2014. PMID: 25667891; PMCID: PMC4307879.
Copy Download .nbib Format: NLM
Isolated metastases of hepatocellular carcinoma in the left atrium, unresponsive to treatment with sorafenib.

Molecular and clinical oncology

Fukuoka K, Masachika E, Honda M, Tsukamoto Y, Nakano T.
PMID: 25798274
Mol Clin Oncol. 2015 Mar;3(2):397-399. doi: 10.3892/mco.2014.454. Epub 2014 Nov 10.

Isolated metastases in the left atrium that are discontinuous with an intrahepatic hepatocellular carcinoma (HCC) are extremely rare. This is the case report of a 46-year-old male patient with pulmonary metastases from HCC, who presented with a tumor in...

Cite
Fukuoka K, Masachika E, Honda M, et al. Isolated metastases of hepatocellular carcinoma in the left atrium, unresponsive to treatment with sorafenib. Mol Clin Oncol. 2014;3(2):397-399doi: 10.3892/mco.2014.454.
Fukuoka, K., Masachika, E., Honda, M., Tsukamoto, Y., & Nakano, T. (2015). Isolated metastases of hepatocellular carcinoma in the left atrium, unresponsive to treatment with sorafenib. Molecular and clinical oncology, 3(2), 397-399. https://doi.org/10.3892/mco.2014.454
Fukuoka, Kazuya, et al. "Isolated metastases of hepatocellular carcinoma in the left atrium, unresponsive to treatment with sorafenib." Molecular and clinical oncology vol. 3,2 (2015): 397-399. doi: https://doi.org/10.3892/mco.2014.454
Fukuoka K, Masachika E, Honda M, Tsukamoto Y, Nakano T. Isolated metastases of hepatocellular carcinoma in the left atrium, unresponsive to treatment with sorafenib. Mol Clin Oncol. 2015 Mar;3(2):397-399. doi: 10.3892/mco.2014.454. Epub 2014 Nov 10. PMID: 25798274; PMCID: PMC4360526.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1532 entries